Tech Company Financing Transactions
SmartZyme Funding Round
OrbiMed, Virtus Inspire Ventures and WallachBeth Capital joined a Series B funding round for SmartZyme. This venture round was announced by the company on 3/15/2018.
Transaction Overview
Company Name
Announced On
3/15/2018
Transaction Type
Venture Equity
Amount
Unknown
Round
Series B
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
575 Lexington Ave.
New York, NY 10022
USA
New York, NY 10022
USA
Phone
Website
Email Address
Not Recorded
Overview
SmartZyme Innovation is a Life Science company using a proprietary technological platform for protein design and engineering in accordance with industry required specifications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Shilo Ben-Zeev
Chief Financial Officer
Motty Hershkowitz
Chief Operating Officer
Eyal Sandach
Chief Technical Officer
David Baram
Browse more venture capital transactions:
Prev: 3/15/2018: Skyroam venture capital transaction
Next: 3/15/2018: LandscapeHub venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs